PRIMARY STUDY
Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes
Key Findings: THCV can induce neuroprotection, appetite suppression, and glycemic control.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Nigeria, United States
Year of Pub: 2020
Cannabinoids Studied: Tetrahydrocannabivarin (THCV)
Phytocannabinoid Source: Unspecified
Citation: Abioye A, et al. Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes. J Cannabis Res. 2020; 2:6. doi: 10.1186/s42238-020-0016-7
Authors: Abioye A, Ayodele O, Marinkovic A, Patidar R, Akinwekomi A, Sanyaolu A
